½ÃÀ庸°í¼­
»óǰÄÚµå
1484157

¼¼°èÀÇ ³ªÀß ½ºÇø°Æ® ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® - ¸ÞÄ¿´ÏÁòº°, ¿ëµµº°, À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Àç·á À¯Çüº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2024-2031³â)

Global Nasal Splints Market Size, Share & Trends Analysis Report By Mechanism (Intranasal, and External), By Application (Septoplasty, and Rhinoplasty), By Type, By End-user, By Material Type, By Regional Outlook and Forecast, 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 413 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ³ªÀß ½ºÇø°Æ® ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È CAGR 4.9%·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³â¿¡´Â ½ÃÀå ±Ô¸ð°¡ 6,190¸¸ 8,500´ë¿¡ µµ´ÞÇÏ¿© 15.4%(2020-2023) ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª ÄÚ ¼ö¼úÀº °í°¡ÀÇ ¼ö¼úÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ¿Ü°ú ÀÇ»ç ºñ¿ë, ÀÔ¿øºñ, ¸¶Ãë ºñ¿ë ¹× ¼ö¼ú ÈÄ °ü¸®¿Í °ü·ÃµÈ ºñ¿ëÀÌ Á¾Á¾ ¹ß»ýÇÕ´Ï´Ù. ³ªÀß ½ºÇø°Æ®Àº ¿Ü°ú Àû °³ÀÔ¿¡ ºñÇØ »ó´ëÀûÀ¸·Î Àú·ÅÇϱ⠶§¹®¿¡ ƯÈ÷ ºÎ¸ñ ¿ä¹ýÀÌ Ä§½ÀÀû ¼ö¼ú¾øÀÌ ÃæºÐÇÑÁöÁö, ¾ÈÁ¤È­ ¶Ç´Â ¼ö¼ú ÈÄ Ä¡·á¸¦ Á¦°øÇÒ ¼öÀÖ´Â °æ¿ì ºñ¿ë È¿À²¼º Ãø¸é¿¡¼­ ¼±È£µÇ´Â °ÍÀ¸·Î °£ÁÖ µÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ Ãø¸éÀº ÇâÈÄ ¸î ³âµ¿¾È ³ªÀß ½ºÇø°Æ®¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á Á¦°ø¾÷ü¿Í ÀÇ·á±â°üÀº Äڷγª19 °Ë»ç, Ä¡·á, ¹é½Å Á¢Á¾¿¡ ¿ì¼±¼øÀ§¸¦ µÎ°í ºñ°­ ºÎ¸ñ Ä¡·á¿Í °°Àº Äڷγª19¿Í °ü·ÃÀÌ ¾ø´Â ÀÇ·á °³ÀÔ¿¡ °ü½É°ú ÀÚ¿øÀ» ½ñÁö ¾Ê¾Ò½À´Ï´Ù. ºñ°­ Áõ»ó¿¡ ´ëÇØ ÀÇ»çÀÇ ÁøÂûÀ» ¹Þ´Â °ÍÀ» ÁÖÀúÇϸ鼭 ºñ°­ ºÎ¸ñ ¹× ±âŸ °ü·Ã Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ °¨¼ÒÇß½À´Ï´Ù. µû¶ó¼­ Äڷγª19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¸ÞÄ¿´ÏÁòÀÇ Àü¸Á

¸ÞÄ¿´ÏÁò¿¡ µû¶ó ½ÃÀåÀº ºñ°­ ³»ºÎ¿Í ¿ÜºÎ·Î ³ª´µ¸ç, 2023³â¿¡´Â ¿ÜºÎ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 44.37%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ¿ÜºÎ ºÎ¸ñÀº ÀÌ·¯ÇÑ Áõ»óÀ» ÇØ°áÇϱâÀ§ÇÑ ºñ¼ö¼ú Àû Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÏ¿© ³»ºÎ ¼ö¼úÀ̳ª ħ½ÀÀû ÀýÂ÷ ¾øÀ̵µ ±â°èÀû Áö¿øÀ» Á¦°øÇÏ°í ºñ°­ °ø±â È帧À» °³¼±ÇÕ´Ï´Ù. ¿ÜºÎ ³ªÀß ½ºÇø°Æ®ÀÇ ºñ ħ½À¼ºÀº ¼ö¼úÀ̳ª ÄÚ Æ÷ÀåÀÇ ´ë¾ÈÀ» ã´Â ȯÀÚ¿¡°Ô ¸Å·ÂÀûÀÔ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¿äÀÎÀº ºÎ¹®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

¿ëµµ Àü¸Á

¿ëµµ¿¡ µû¶ó ½ÃÀåÀº ÄÚ ¼ºÇü¼ú°ú ÄÚ Áß°Ý ¼ºÇü¼ú·Î ³ª´¹´Ï´Ù. ÄÚ ¼ºÇü¼ú ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 35.85%ÀÇ Áß¿äÇÑ ¼öÀÍ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ¼ö·® Ãø¸é¿¡¼­ ÀÌ ºÎ¹®Àº 2023³â 2,079¸¸ 6,400´ë¸¦ ¼ÒºñÇß½À´Ï´Ù. ºñ°­ ¼ºÇü¼úÀº ¹ÌÀû °³¼±, È£Èí °³¼±, ÄÚÀÇ ±â´Éº¸´Ù ÃÖ¼Ò Ä§½ÀÀûÀÌ°í ±â´ÉÀûÀÎ ÄÚ ¼ºÇü¼ú ±â¼úÀÌ ¿ì¼±½ÃµÇ´Â »õ·Î¿î ÆÐÅÏÀÌ Á¸ÀçÇÕ´Ï´Ù. ÄÚ ¸·Èû, ºñÁ߰ݸ¸°îÁõ ¶Ç´Â ºñ¹ëºêÀÇ ºØ±«¸¦ ´Ù·ç´Â ±â´ÉÀû ÄÚ ¼ºÇü¼úÀº Á¾Á¾ °ø±â È帧°ú ÄÚ ±â´ÉÀ» °³¼±Çϱâ À§ÇÑ ¿Ü°úÀû °³ÀÔÀ» Æ÷ÇÔÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ Ãø¸éÀº ºÎ¹®¿¡ À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

À¯Çüº° Àü¸Á

À¯Çü¿¡ µû¶ó ½ÃÀåÀº °¡´Ü¼º, ±âµµ, ÀÌ¸ÅÆÐ·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡´Â ±âµµ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 34.90%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ±âµµ ºñ°­ ºÎ¸ñÀÇ Àû¿ëÀº ºñ°­ ¼ö¼ú ¹× ¿Ü»ó °ü¸®¿Í °°Àº ÀüÅëÀûÀÎ ÀûÀÀÁõÀ» ³Ñ¾î±âµµ Áö¿ø ¹× ¾ÈÁ¤È­°¡ µµ¿òÀ̵Ǵ ´õ ±¤¹üÀ§ÇÑ ÀÓ»ó ½Ã³ª¸®¿À¸¦ Æ÷ÇÔÇϵµ·Ï È®ÀåµÇ°í ÀÖ½À´Ï´Ù. ºñÁß°Ý ¼ºÇü¼ú ¶Ç´Â ÄÚ ¼ºÇü¼ú ÈÄ ¼ö¼ú ÈÄ ºÎ¸ñ ¿Ü¿¡µµ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA), ¸¸¼º ÄÚ¸·Èû, ¾Ë·¹¸£±â¼º ºñ¿° ¹× ±âŸ ±âµµ °ü·Ã ÁúȯÀ» °ü¸®Çϱâ À§ÇØ ±âµµ ºñ°­ ºÎ¸ñÀÌ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ Àü¸Á

ÃÖÁ¾ »ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº º´¿ø°ú ¿Ü·¡È¯ÀÚ·Î ³ª´¹´Ï´Ù. º´¿ø ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 46.67%ÀÇ Áß¿äÇÑ ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¼ö·®¸é¿¡¼­ÀÌ ºÎ¹®Àº 2023³â¿¡ 2,567 ¸¸ 3,500 ´ë¸¦ ¼ÒºñÇß½À´Ï´Ù. º´¿øÀÌ ½Ã¼³ ¾÷±×·¹À̵å, ÷´Ü ÀÇ·á±â±â ȹµæ ¹× Àü¹® ¼­ºñ½º È®Àå¿¡ ÅõÀÚÇÔ¿¡ µû¶ó º´¿øÀº ºÎ¸ñ Ä¡·á°¡ ÇÊ¿äÇÑ ºñ°­ Àå¾Ö¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÀÇÇÐÀû »óÅ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Ä¡·á¸¦ Á¡Á¡ ´õ ¸¹ÀÌ Á¦°øÇÒ ¼öÀÖÀ» °ÍÀÔ´Ï´Ù.

¼ÒÀç À¯Çüº° Àü¸Á

Àç·á À¯Çü¿¡ µû¶ó ½ÃÀåÀº ÇÃ¶ó½ºÆ½ ºÎ¸ñ, ±Ý¼Ó ºÎ¸ñ, ½Ç¸®ÄÜ ºÎ¸ñ ¹× ±âŸ·Î ³ª´µ¸ç, 2023³â¿¡´Â ÇÃ¶ó½ºÆ½ ºÎ¸ñ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 32.79%ÀÇ ½ÇÁúÀûÀÎ ¼öÀÍ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ÇÃ¶ó½ºÆ½ ºÎ¸ñÀº ºñ°­ ±âµµ¿¡ ¾ÈÁ¤ÀûÀÎ ÁöÁö ÇÁ·¹ÀÓ¿öÅ©¸¦ Á¦°øÇϰí Á¶Á÷ Àڱذú ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϱ⠶§¹®¿¡ ¼ö¼ú ÈÄ ¶Ç´Â ¿Ü»ó ÈÄ È¯°æ¿¡¼­ Àå±â°£ »ç¿ëÇϱ⿡ ÀûÇÕÇÕ´Ï´Ù. ÇÃ¶ó½ºÆ½ ¼ÒÀçÀÇ ´ÙÀç´Ù´ÉÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ °³º° ȯÀÚÀÇ ÇØºÎÇÐÀû ±¸Á¶¿Í Ä¡·á ¿ä±¸¿¡ ¸Â´Â ¸ÂÃãÇü ºÎ¸ñ ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ ºÐ¾ß´Â ÇâÈÄ ¸î ³âµ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 36.80%ÀÇ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÏ¹Ì´Â ºñÁ߰ݸ¸°îÁõ, ºñ¹ëºê ºØ±«, ¸¸¼º ºÎºñµ¿¿°, ºñ°­ ¿Ü»ó°ú °°Àº ºñ°­ ÁúȯÀÌ »ó´çÈ÷ ³Î¸® ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº Á¾Á¾ ¼ö¼ú ÈÄ Áö¿ø ¹× ¾ÈÁ¤È­¸¦ À§ÇØ ºñ°­ º¸Á¶±â¸¦ Æ÷ÇÔÇÑ ÀÇ·á ¶Ç´Â ¿Ü°ú Àû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¿äÀÎÀº ºÎ¹®ÀÇ ¼ºÀå Áõ°¡¿¡ ±â¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • °³¿ä
      • ½ÃÀå ±¸¼º°ú ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°è ½ÃÀå : ¸ÞÄ¿´ÏÁòº°

  • ¼¼°èÀÇ ºñ°­³» ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ¿ÜºÎ ½ÃÀå : Áö¿ªº°

Á¦5Àå ¼¼°è ½ÃÀå : ¿ëµµº°

  • ¼¼°èÀÇ ºñÁß°Ý ¼ºÇü¼ú ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÄÚ ¼ºÇü¼ú ½ÃÀå : Áö¿ªº°

Á¦6Àå ¼¼°è ½ÃÀå : À¯Çüº°

  • ¼¼°èÀÇ Malleable ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Airway ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Bivalve ½ÃÀå : Áö¿ªº°

Á¦7Àå ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼¼°èÀÇ ¿Ü·¡ ȯÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ º´¿ø ½ÃÀå : Áö¿ªº°

Á¦8Àå ¼¼°è ½ÃÀå : ¼ÒÀç À¯Çüº°

  • ¼¼°èÀÇ ½Ç¸®ÄÜ ½ºÇø°Æ® ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÇÃ¶ó½ºÆ½ ÇÁ¸°Æ® ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±Ý¼Ó ½ºÇø°Æ® ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ ½ÃÀå : Áö¿ªº°

Á¦9Àå ¼¼°è ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ºÏ¹Ì ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
    • À¯·´ ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • ½Ì°¡Æ÷¸£
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«/Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«/Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«/Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ °³¿ä

  • Olympus Corporation
  • Medtronic PLC
  • Smith & Nephew PLC
  • Surgiform Technology Ltd(STL Group, Inc.)
  • Teleflex Incorporated
  • ENTPROMED Healthcare Products Inc
  • E Benson Hood Laboratories, Inc.
  • Audio Technologies SRL(Innovative-RFK Spa)
  • Anthony Products, Inc
  • Boston Medical Products, Inc(Bess AG)

Á¦11Àå ³ªÀß ½ºÇø°Æ® ½ÃÀåÀ» À§ÇÑ ¼º°ø Çʼö Á¶°Ç

LSH 24.05.31

The Global Nasal Splints Market size is expected to reach $2.2 billion by 2031, rising at a market growth of 4.9% CAGR during the forecast period. In the year 2023, the market attained a volume of 61,908.5 thousand units, experiencing a growth of 15.4% (2020-2023).

In 2023, the Europe segment acquired a considerable revenue share in the nasal splints market. Europe is home to some of the world's leading medical device manufacturers and innovators, contributing to developing advanced nasal splint technologies and solutions. Therefore, the segment generated 28.73% revenue share in 2031. Also, Germany would consume 3,227.40 thousand units of Malleable splints by 2031. Companies in the region have invested in research and development efforts to enhance the design, materials, and functionality of nose splints, resulting in the introduction of more effective and patient-friendly splint solutions. Therefore, these aspects can boost the expansion of the segment.

The prevalence of nasal conditions such as deviated septum, nasal fractures, and nasal valve collapse contributes significantly to the demand for nose splints. Surgical procedures or interventions such as nasal valve reconstruction may be performed to address this issue. Nasal can be used post-surgery to support the reconstructed nasal valves and maintain airflow. Hence, these factors can increase demand. Additionally, Rhinoplasty has become increasingly popular worldwide, driven by cosmetic and functional motivations. Rhinoplasty surgery often results in swelling and edema (fluid retention) around the nasal area. Hence, these factors can boost the growth of the nose splints market.

However, Nasal surgeries can be expensive procedures, often involving costs related to surgeon fees, hospitalization, anesthesia, and postoperative care. Nose splints, being relatively inexpensive compared to surgical interventions, may be viewed favorably in terms of cost-effectiveness, particularly for conditions where splint therapy can provide adequate support, stabilization, or postoperative care without invasive surgery. Thus, these aspects can lead to a downturn in the demand for nose splints in the upcoming years.

Healthcare providers and facilities prioritized COVID-19 testing, treatment, and vaccination efforts, diverting attention and resources from non-COVID-19-related medical interventions, including nasal splint therapy. This reluctance to seek medical attention for nasal conditions contributed to a decline in the demand for nose splints and other related treatments. Therefore, the COVID-19 pandemic had a negative impact on the market.

Mechanism Outlook

Based on mechanism, the market is divided into intranasal and external. In 2023, the external segment witnessed 44.37% revenue share in the market. External splints offer a nonsurgical approach to addressing these conditions, providing mechanical support, and improving nasal airflow without the need for internal manipulation or invasive procedures. The noninvasive nature of external nose splints appeals to patients seeking alternatives to surgery or nasal packing. Hence, these factors will fuel the demand in the segment.

Application Outlook

Based on application, the market is divided into rhinoplasty and septoplasty. The rhinoplasty segment recorded 35.85% significant revenue share in the market in 2023. In terms of volume the segment consumed 20,796.4 thousand units in 2023. An emerging pattern exists wherein minimally invasive and functional rhinoplasty techniques take precedence over aesthetic enhancement, respiratory improvement, and nasal function. Functional rhinoplasty procedures addressing nasal obstruction, septal deviation, or nasal valve collapse often involve surgical interventions to improve airflow and nasal function. Thus, these aspects can pose lucrative growth prospects for the segment.

Type Outlook

Based on type, the market is segmented into malleable, airway, and bivalve. In 2023, the airway segment garnered 34.90% revenue share in the market. The applications of airway nose splints have expanded beyond traditional indications such as nasal surgery and trauma management to encompass a broader range of clinical scenarios where airway support and stabilization are beneficial. In addition to postoperative splinting following septoplasty or rhinoplasty procedures, airway nose splints are increasingly utilized to manage obstructive sleep apnea (OSA), chronic nasal congestion, allergic rhinitis, and other airway-related conditions.

End-user Outlook

Based on end-user, the market is bifurcated into hospitals and outpatients. The hospitals segment held 46.67% significant revenue share in the market in 2023. In terms of volume the segment consumed 25,673.5 thousand units in 2023. As hospitals invest in upgrading their facilities, acquiring advanced medical equipment, and expanding their specialist services, they can increasingly provide comprehensive care for a diverse range of medical conditions, including nasal disorders requiring splint therapy.

Material Type Outlook

Based on material type, the market is divided into plastic splints, metal splints, silicon splints, and others. In 2023, the plastic splints segment witnessed 32.79% substantial revenue share in the market. Plastic splints provide a stable and supportive framework for the nasal airway while minimizing tissue irritation and discomfort, making them well-suited for prolonged use in postoperative and post-traumatic settings. The versatility of plastic materials allows for the development of customizable splinting solutions tailored to individual patient anatomy and treatment needs. Hence, the segment will expand rapidly in the coming years.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 36.80% highest revenue share in the market in 2023. North America has a significant prevalence of nasal conditions such as deviated septum, nasal valve collapse, chronic rhinosinusitis, and nasal trauma, among others. These conditions often require medical or surgical interventions, including nose splints for postoperative support and stabilization. Thus, these factors can contribute to increased growth of the segment.

List of Key Companies Profiled

  • Olympus Corporation
  • Medtronic PLC
  • Smith & Nephew PLC
  • Surgiform Technology Ltd. (STL Group, Inc.)
  • Teleflex Incorporated
  • ENTPROMED Healthcare Products Inc.
  • E. Benson Hood Laboratories, Inc.
  • Audio Technologies SRL (Innovative-RFK Spa)
  • Anthony Products Inc.
  • Boston Medical Products, Inc. (Bess AG)

Global Nasal Splints Market Report Segmentation

By Mechanism (Volume, Thousand Units, USD Billion, 2020-31)

  • Intranasal
  • External

By Application (Volume, Thousand Units, USD Billion, 2020-31)

  • Septoplasty
  • Rhinoplasty

By Type (Volume, Thousand Units, USD Billion, 2020-31)

  • Malleable
  • Airway
  • Bivalve

By End-user (Volume, Thousand Units, USD Billion, 2020-31)

  • Outpatients
  • Hospitals

By Material Type (Volume, Thousand Units, USD Billion, 2020-31)

  • Silicon Splints
  • Plastic Splints
  • Metal Splints
  • Others

By Geography (Volume, Thousand Units, USD Billion, 2020-31)

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global Nasal Splints Market, by Mechanism
    • 1.4.2Global Nasal Splints Market, by Application
    • 1.4.3Global Nasal Splints Market, by Type
    • 1.4.4Global Nasal Splints Market, by End-user
    • 1.4.5Global Nasal Splints Market, by Material Type
    • 1.4.6Global Nasal Splints Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Global Nasal Splints Market by Mechanism

  • 4.1Global Intranasal Market by Region
  • 4.2Global External Market by Region

Chapter 5.Global Nasal Splints Market by Application

  • 5.1Global Septoplasty Market by Region
  • 5.2Global Rhinoplasty Market by Region

Chapter 6.Global Nasal Splints Market by Type

  • 6.1Global Malleable Market by Region
  • 6.2Global Airway Market by Region
  • 6.3Global Bivalve Market by Region

Chapter 7.Global Nasal Splints Market by End-user

  • 7.1Global Outpatients Market by Region
  • 7.2Global Hospitals Market by Region

Chapter 8.Global Nasal Splints Market by Material Type

  • 8.1Global Silicon Splints Market by Region
  • 8.2Global Plastic Splints Market by Region
  • 8.3Global Metal Splints Market by Region
  • 8.4Global Others Market by Region

Chapter 9.Global Nasal Splints Market by Region

  • 9.1North America Nasal Splints Market
    • 9.1.1North America Nasal Splints Market by Mechanism
      • 9.1.1.1North America Intranasal Market by Region
      • 9.1.1.2North America External Market by Region
    • 9.1.2North America Nasal Splints Market by Application
      • 9.1.2.1North America Septoplasty Market by Country
      • 9.1.2.2North America Rhinoplasty Market by Country
    • 9.1.3North America Nasal Splints Market by Type
      • 9.1.3.1North America Malleable Market by Country
      • 9.1.3.2North America Airway Market by Country
      • 9.1.3.3North America Bivalve Market by Country
    • 9.1.4North America Nasal Splints Market by End-user
      • 9.1.4.1North America Outpatients Market by Country
      • 9.1.4.2North America Hospitals Market by Country
    • 9.1.5North America Nasal Splints Market by Material Type
      • 9.1.5.1North America Silicon Splints Market by Country
      • 9.1.5.2North America Plastic Splints Market by Country
      • 9.1.5.3North America Metal Splints Market by Country
      • 9.1.5.4North America Others Market by Country
    • 9.1.6North America Nasal Splints Market by Country
      • 9.1.6.1US Nasal Splints Market
        • 9.1.6.1.1US Nasal Splints Market by Mechanism
        • 9.1.6.1.2US Nasal Splints Market by Application
        • 9.1.6.1.3US Nasal Splints Market by Type
        • 9.1.6.1.4US Nasal Splints Market by End-user
        • 9.1.6.1.5US Nasal Splints Market by Material Type
      • 9.1.6.2Canada Nasal Splints Market
        • 9.1.6.2.1Canada Nasal Splints Market by Mechanism
        • 9.1.6.2.2Canada Nasal Splints Market by Application
        • 9.1.6.2.3Canada Nasal Splints Market by Type
        • 9.1.6.2.4Canada Nasal Splints Market by End-user
        • 9.1.6.2.5Canada Nasal Splints Market by Material Type
      • 9.1.6.3Mexico Nasal Splints Market
        • 9.1.6.3.1Mexico Nasal Splints Market by Mechanism
        • 9.1.6.3.2Mexico Nasal Splints Market by Application
        • 9.1.6.3.3Mexico Nasal Splints Market by Type
        • 9.1.6.3.4Mexico Nasal Splints Market by End-user
        • 9.1.6.3.5Mexico Nasal Splints Market by Material Type
      • 9.1.6.4Rest of North America Nasal Splints Market
        • 9.1.6.4.1Rest of North America Nasal Splints Market by Mechanism
        • 9.1.6.4.2Rest of North America Nasal Splints Market by Application
        • 9.1.6.4.3Rest of North America Nasal Splints Market by Type
        • 9.1.6.4.4Rest of North America Nasal Splints Market by End-user
        • 9.1.6.4.5Rest of North America Nasal Splints Market by Material Type
  • 9.2Europe Nasal Splints Market
    • 9.2.1Europe Nasal Splints Market by Mechanism
      • 9.2.1.1Europe Intranasal Market by Country
      • 9.2.1.2Europe External Market by Country
    • 9.2.2Europe Nasal Splints Market by Application
      • 9.2.2.1Europe Septoplasty Market by Country
      • 9.2.2.2Europe Rhinoplasty Market by Country
    • 9.2.3Europe Nasal Splints Market by Type
      • 9.2.3.1Europe Malleable Market by Country
      • 9.2.3.2Europe Airway Market by Country
      • 9.2.3.3Europe Bivalve Market by Country
    • 9.2.4Europe Nasal Splints Market by End-user
      • 9.2.4.1Europe Outpatients Market by Country
      • 9.2.4.2Europe Hospitals Market by Country
    • 9.2.5Europe Nasal Splints Market by Material Type
      • 9.2.5.1Europe Silicon Splints Market by Country
      • 9.2.5.2Europe Plastic Splints Market by Country
      • 9.2.5.3Europe Metal Splints Market by Country
      • 9.2.5.4Europe Others Market by Country
    • 9.2.6Europe Nasal Splints Market by Country
      • 9.2.6.1Germany Nasal Splints Market
        • 9.2.6.1.1Germany Nasal Splints Market by Mechanism
        • 9.2.6.1.2Germany Nasal Splints Market by Application
        • 9.2.6.1.3Germany Nasal Splints Market by Type
        • 9.2.6.1.4Germany Nasal Splints Market by End-user
        • 9.2.6.1.5Germany Nasal Splints Market by Material Type
      • 9.2.6.2UK Nasal Splints Market
        • 9.2.6.2.1UK Nasal Splints Market by Mechanism
        • 9.2.6.2.2UK Nasal Splints Market by Application
        • 9.2.6.2.3UK Nasal Splints Market by Type
        • 9.2.6.2.4UK Nasal Splints Market by End-user
        • 9.2.6.2.5UK Nasal Splints Market by Material Type
      • 9.2.6.3France Nasal Splints Market
        • 9.2.6.3.1France Nasal Splints Market by Mechanism
        • 9.2.6.3.2France Nasal Splints Market by Application
        • 9.2.6.3.3France Nasal Splints Market by Type
        • 9.2.6.3.4France Nasal Splints Market by End-user
        • 9.2.6.3.5France Nasal Splints Market by Material Type
      • 9.2.6.4Russia Nasal Splints Market
        • 9.2.6.4.1Russia Nasal Splints Market by Mechanism
        • 9.2.6.4.2Russia Nasal Splints Market by Application
        • 9.2.6.4.3Russia Nasal Splints Market by Type
        • 9.2.6.4.4Russia Nasal Splints Market by End-user
        • 9.2.6.4.5Russia Nasal Splints Market by Material Type
      • 9.2.6.5Spain Nasal Splints Market
        • 9.2.6.5.1Spain Nasal Splints Market by Mechanism
        • 9.2.6.5.2Spain Nasal Splints Market by Application
        • 9.2.6.5.3Spain Nasal Splints Market by Type
        • 9.2.6.5.4Spain Nasal Splints Market by End-user
        • 9.2.6.5.5Spain Nasal Splints Market by Material Type
      • 9.2.6.6Italy Nasal Splints Market
        • 9.2.6.6.1Italy Nasal Splints Market by Mechanism
        • 9.2.6.6.2Italy Nasal Splints Market by Application
        • 9.2.6.6.3Italy Nasal Splints Market by Type
        • 9.2.6.6.4Italy Nasal Splints Market by End-user
        • 9.2.6.6.5Italy Nasal Splints Market by Material Type
      • 9.2.6.7Rest of Europe Nasal Splints Market
        • 9.2.6.7.1Rest of Europe Nasal Splints Market by Mechanism
        • 9.2.6.7.2Rest of Europe Nasal Splints Market by Application
        • 9.2.6.7.3Rest of Europe Nasal Splints Market by Type
        • 9.2.6.7.4Rest of Europe Nasal Splints Market by End-user
        • 9.2.6.7.5Rest of Europe Nasal Splints Market by Material Type
  • 9.3Asia Pacific Nasal Splints Market
    • 9.3.1Asia Pacific Nasal Splints Market by Mechanism
      • 9.3.1.1Asia Pacific Intranasal Market by Country
      • 9.3.1.2Asia Pacific External Market by Country
    • 9.3.2Asia Pacific Nasal Splints Market by Application
      • 9.3.2.1Asia Pacific Septoplasty Market by Country
      • 9.3.2.2Asia Pacific Rhinoplasty Market by Country
    • 9.3.3Asia Pacific Nasal Splints Market by Type
      • 9.3.3.1Asia Pacific Malleable Market by Country
      • 9.3.3.2Asia Pacific Airway Market by Country
      • 9.3.3.3Asia Pacific Bivalve Market by Country
    • 9.3.4Asia Pacific Nasal Splints Market by End-user
      • 9.3.4.1Asia Pacific Outpatients Market by Country
      • 9.3.4.2Asia Pacific Hospitals Market by Country
    • 9.3.5Asia Pacific Nasal Splints Market by Material Type
      • 9.3.5.1Asia Pacific Silicon Splints Market by Country
      • 9.3.5.2Asia Pacific Plastic Splints Market by Country
      • 9.3.5.3Asia Pacific Metal Splints Market by Country
      • 9.3.5.4Asia Pacific Others Market by Country
    • 9.3.6Asia Pacific Nasal Splints Market by Country
      • 9.3.6.1China Nasal Splints Market
        • 9.3.6.1.1China Nasal Splints Market by Mechanism
        • 9.3.6.1.2China Nasal Splints Market by Application
        • 9.3.6.1.3China Nasal Splints Market by Type
        • 9.3.6.1.4China Nasal Splints Market by End-user
        • 9.3.6.1.5China Nasal Splints Market by Material Type
      • 9.3.6.2Japan Nasal Splints Market
        • 9.3.6.2.1Japan Nasal Splints Market by Mechanism
        • 9.3.6.2.2Japan Nasal Splints Market by Application
        • 9.3.6.2.3Japan Nasal Splints Market by Type
        • 9.3.6.2.4Japan Nasal Splints Market by End-user
        • 9.3.6.2.5Japan Nasal Splints Market by Material Type
      • 9.3.6.3India Nasal Splints Market
        • 9.3.6.3.1India Nasal Splints Market by Mechanism
        • 9.3.6.3.2India Nasal Splints Market by Application
        • 9.3.6.3.3India Nasal Splints Market by Type
        • 9.3.6.3.4India Nasal Splints Market by End-user
        • 9.3.6.3.5India Nasal Splints Market by Material Type
      • 9.3.6.4South Korea Nasal Splints Market
        • 9.3.6.4.1South Korea Nasal Splints Market by Mechanism
        • 9.3.6.4.2South Korea Nasal Splints Market by Application
        • 9.3.6.4.3South Korea Nasal Splints Market by Type
        • 9.3.6.4.4South Korea Nasal Splints Market by End-user
        • 9.3.6.4.5South Korea Nasal Splints Market by Material Type
      • 9.3.6.5Singapore Nasal Splints Market
        • 9.3.6.5.1Singapore Nasal Splints Market by Mechanism
        • 9.3.6.5.2Singapore Nasal Splints Market by Application
        • 9.3.6.5.3Singapore Nasal Splints Market by Type
        • 9.3.6.5.4Singapore Nasal Splints Market by End-user
        • 9.3.6.5.5Singapore Nasal Splints Market by Material Type
      • 9.3.6.6Malaysia Nasal Splints Market
        • 9.3.6.6.1Malaysia Nasal Splints Market by Mechanism
        • 9.3.6.6.2Malaysia Nasal Splints Market by Application
        • 9.3.6.6.3Malaysia Nasal Splints Market by Type
        • 9.3.6.6.4Malaysia Nasal Splints Market by End-user
        • 9.3.6.6.5Malaysia Nasal Splints Market by Material Type
      • 9.3.6.7Rest of Asia Pacific Nasal Splints Market
        • 9.3.6.7.1Rest of Asia Pacific Nasal Splints Market by Mechanism
        • 9.3.6.7.2Rest of Asia Pacific Nasal Splints Market by Application
        • 9.3.6.7.3Rest of Asia Pacific Nasal Splints Market by Type
        • 9.3.6.7.4Rest of Asia Pacific Nasal Splints Market by End-user
        • 9.3.6.7.5Rest of Asia Pacific Nasal Splints Market by Material Type
  • 9.4LAMEA Nasal Splints Market
    • 9.4.1LAMEA Nasal Splints Market by Mechanism
      • 9.4.1.1LAMEA Intranasal Market by Country
      • 9.4.1.2LAMEA External Market by Country
    • 9.4.2LAMEA Nasal Splints Market by Application
      • 9.4.2.1LAMEA Septoplasty Market by Country
      • 9.4.2.2LAMEA Rhinoplasty Market by Country
    • 9.4.3LAMEA Nasal Splints Market by Type
      • 9.4.3.1LAMEA Malleable Market by Country
      • 9.4.3.2LAMEA Airway Market by Country
      • 9.4.3.3LAMEA Bivalve Market by Country
    • 9.4.4LAMEA Nasal Splints Market by End-user
      • 9.4.4.1LAMEA Outpatients Market by Country
      • 9.4.4.2LAMEA Hospitals Market by Country
    • 9.4.5LAMEA Nasal Splints Market by Material Type
      • 9.4.5.1LAMEA Silicon Splints Market by Country
      • 9.4.5.2LAMEA Plastic Splints Market by Country
      • 9.4.5.3LAMEA Metal Splints Market by Country
      • 9.4.5.4LAMEA Others Market by Country
    • 9.4.6LAMEA Nasal Splints Market by Country
      • 9.4.6.1Brazil Nasal Splints Market
        • 9.4.6.1.1Brazil Nasal Splints Market by Mechanism
        • 9.4.6.1.2Brazil Nasal Splints Market by Application
        • 9.4.6.1.3Brazil Nasal Splints Market by Type
        • 9.4.6.1.4Brazil Nasal Splints Market by End-user
        • 9.4.6.1.5Brazil Nasal Splints Market by Material Type
      • 9.4.6.2Argentina Nasal Splints Market
        • 9.4.6.2.1Argentina Nasal Splints Market by Mechanism
        • 9.4.6.2.2Argentina Nasal Splints Market by Application
        • 9.4.6.2.3Argentina Nasal Splints Market by Type
        • 9.4.6.2.4Argentina Nasal Splints Market by End-user
        • 9.4.6.2.5Argentina Nasal Splints Market by Material Type
      • 9.4.6.3UAE Nasal Splints Market
        • 9.4.6.3.1UAE Nasal Splints Market by Mechanism
        • 9.4.6.3.2UAE Nasal Splints Market by Application
        • 9.4.6.3.3UAE Nasal Splints Market by Type
        • 9.4.6.3.4UAE Nasal Splints Market by End-user
        • 9.4.6.3.5UAE Nasal Splints Market by Material Type
      • 9.4.6.4Saudi Arabia Nasal Splints Market
        • 9.4.6.4.1Saudi Arabia Nasal Splints Market by Mechanism
        • 9.4.6.4.2Saudi Arabia Nasal Splints Market by Application
        • 9.4.6.4.3Saudi Arabia Nasal Splints Market by Type
        • 9.4.6.4.4Saudi Arabia Nasal Splints Market by End-user
        • 9.4.6.4.5Saudi Arabia Nasal Splints Market by Material Type
      • 9.4.6.5South Africa Nasal Splints Market
        • 9.4.6.5.1South Africa Nasal Splints Market by Mechanism
        • 9.4.6.5.2South Africa Nasal Splints Market by Application
        • 9.4.6.5.3South Africa Nasal Splints Market by Type
        • 9.4.6.5.4South Africa Nasal Splints Market by End-user
        • 9.4.6.5.5South Africa Nasal Splints Market by Material Type
      • 9.4.6.6Nigeria Nasal Splints Market
        • 9.4.6.6.1Nigeria Nasal Splints Market by Mechanism
        • 9.4.6.6.2Nigeria Nasal Splints Market by Application
        • 9.4.6.6.3Nigeria Nasal Splints Market by Type
        • 9.4.6.6.4Nigeria Nasal Splints Market by End-user
        • 9.4.6.6.5Nigeria Nasal Splints Market by Material Type
      • 9.4.6.7Rest of LAMEA Nasal Splints Market
        • 9.4.6.7.1Rest of LAMEA Nasal Splints Market by Mechanism
        • 9.4.6.7.2Rest of LAMEA Nasal Splints Market by Application
        • 9.4.6.7.3Rest of LAMEA Nasal Splints Market by Type
        • 9.4.6.7.4Rest of LAMEA Nasal Splints Market by End-user
        • 9.4.6.7.5Rest of LAMEA Nasal Splints Market by Material Type

Chapter 10.Company Profiles

  • 10.1Olympus Corporation
    • 10.1.1Company Overview
    • 10.1.2Financial Analysis
    • 10.1.3Segmental and Regional Analysis
    • 10.1.4SWOT Analysis
  • 10.2Medtronic PLC
    • 10.2.1Company overview
    • 10.2.2Financial Analysis
    • 10.2.3Segmental and Regional Analysis
    • 10.2.4Research & Development Expenses
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Acquisition and Mergers:
    • 10.2.6SWOT Analysis
  • 10.3Smith & Nephew PLC
    • 10.3.1Company Overview
    • 10.3.2Financial Analysis
    • 10.3.3Segmental and Regional Analysis
    • 10.3.4Research & Development Expenses
    • 10.3.5SWOT Analysis
  • 10.4Surgiform Technology Ltd. (STL Group, Inc.)
    • 10.4.1Company Overview
  • 10.5Teleflex Incorporated
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Segmental Analysis
    • 10.5.4Research & Development Expenses
    • 10.5.5SWOT Analysis
  • 10.6ENTPROMED Healthcare Products Inc.
    • 10.6.1Company Overview
    • 10.6.2SWOT Analysis
  • 10.7E. Benson Hood Laboratories, Inc.
    • 10.7.1Company Overview
  • 10.8Audio Technologies SRL (Innovative-RFK Spa)
    • 10.8.1Company Overview
  • 10.9Anthony Products, Inc.
    • 10.9.1Company Overview
  • 10.10.Boston Medical Products, Inc. (Bess AG)
    • 10.10.1Company Overview

Chapter 11.Winning imperatives of Nasal Splints Market

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦